Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Rybczynski Bernard

19 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Animal Study 7 Receptor Pharmacology 5 Safety 4 Addiction 4 Pharmacology 4 Review Article 3 Toxicity 3 Anxiety 3 Depression 3 OCD 2 Metabolomics 2 Neuroplasticity 2

Journals

The International Journal of Neuropsychopharmacology 2 Comprehensive psychiatry 2 European Journal of Clinical Pharmacology 1 Journal of Psychopharmacology 1 The international journal of neuropsychopharmacology 1 Neuroscience 1 Molecular psychiatry 1 The primary care companion for CNS disorders 1

Publication history

Cardiovascular safety of psilocybin in psychiatric practice: a narrative reviewEuropean Journal of Clinical Pharmacology · 2026-08-01 No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23 204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDERThe International Journal of Neuropsychopharmacology · 2025-07-31 551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHESThe International Journal of Neuropsychopharmacology · 2025-07-31 BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODELThe international journal of neuropsychopharmacology · 2025-02-01 Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice.Neuroscience · 2024-11-01 Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.Molecular psychiatry · 2024-07-01 Medical Uses and Adverse Effects of Psilocybin.The primary care companion for CNS disorders · 2024-05-28 The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.Journal of applied toxicology: JAT · 2024-02-01 Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.Frontiers in pharmacology · 2024-01-01 Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature reviewIJS - International Journal of Sciences · 2023-01-01 Psilocybin for Depression: From Credibility to Feasibility, What's Missing?Pharmaceuticals (Basel, Switzerland) · 2022-12-31 Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.International journal of molecular sciences · 2022-11-16 [Addictions].Revue medicale suisse · 2020-01-15 Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in miceRevista Brasileira de Farmacognosia · 2010-07-01 Application of a radioimmunoassay screening test for detection and management of phencyclidine intoxication.Journal of clinical pharmacology · 1980-01-01 CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.Comprehensive psychiatry · 1964-06-01 CLINICAL OBSERVATIONS OF SIMULTANEOUS HALLUCINOGEN ADMINISTRATION IN IDENTICAL TWINSAmerican Journal of Psychiatry · 1962-03-01 Some observations on psilocybin, a new hallucinogen, in volunteer subjects.Comprehensive psychiatry · 1960-02-01

Author directory